Matthew Tolmach
Eric Charbonneau
United States
2020

Matt Tolmach Productions

Matthew
Tolmach

Tolmach has delivered a string of blockbusters for Sony Pictures, including 2017’s “Jumanji: Welcome to the Jungle” ($962 million worldwide), 2018’s “Venom” ($856 million worldwide), and 2019’s “Jumanji: The Next Level” ($796.6 million worldwide), and he probably would’ve delivered two more in 2020 with “Venom 2: Let There Be Carnage” and “Morbius,” starring Jared Leto, but both had their releases pushed back to 2021 due to the pandemic. His production slate includes another Sony/Marvel entry — “Kraven the Hunter,” directed by J.C. Chandor — and an adaptation of the horror novel “Dark Harvest” for MGM. Tolmach is also exploring his more serious side through documentaries, including 2020’s “Wildflower,” about an 18-year-old honor student who must choose between attending college and raising her disabled parents.  

Career

  • VENOM
  • JUMANJI: WELCOME TO THE JUNGLE
  • SPIDER-MAN: HOMECOMING

Education

  • Beloit College (WI, USA)

Variety Honors

  • 2018 Variety500 Honoree
  • 2019 Variety500 Honoree
Interested in org charts, contact info and more for Matthew Tolmach

News from Variety

'Rough Night's' Lucia Aniello Felt Pressure as a Female Director Not to 'Mess It Up for the Next Woman'

'Rough Night's' Lucia Aniello Felt Pressure as a Female Director Not to 'Mess It Up for the Next Woman'

Monday night's premiere of "Rough Night" had plenty of the usual suspects and big celebrity names. But there were a few details separating this red carpet from the others, like the black party buses, bride-to-be sashes, feather boas, headbands adorned with glittery pink male genitalia, and thumping dance music.It was an appropriate setting for the premiere of a movie about a bachelorette weekend gone awry and a big night for director Lucia Aniello.Much buzz has surrounded Sony's big summer blockbuster,...

MORE NEWS

Want more information on Matthew Tolmach?

Sign up for a free trial to view Matthew's contact info, company details, production deals, & more